Application of LiMgPO4 crystal for proton beam quality control in radiotherapy.

The radioluminescence (RL) emitted by LiMgPO4 detector under proton beam irradiation was investigated in real time at the radiotherapy facility in the Institute of Nuclear Physics Polish Academy of Sciences in Krakow. The facility uses protons accelerated by the AIC-144 isochronous cyclotron up to the energy of 60 MeV. The measurements of RL were carried out using a remote optical fiber device with a luminophore detector and photomultiplier located at opposite ends of the optical fiber. A thin slice of LiMgPO4 doped with Tm (1.2 mol%) crystal was exposed to the proton beam. The tested detector allowed for the measurement of proton beam current, flux fluence and determination of proton beam time structure parameters. The investigation of LiMgPO4 crystal showed its high sensitivity, fast reaction time to irradiation and possibility of application as the detector for control of proton beam parameters.

[Analysis of Performance of the MINItrace Cyclotron before and after Upgrade].

OBJECTIVE: To compare the performance of the GE cyclotron MINItrace system before and after the upgrade. METHODS: The upgrade of the MINItrace system included replacing the silver target with the Nb syetem and adopting the latest RF control and management system and lastest ion source system.The failrue rate and production efficiency were retrospectively analyzed before and after the upgrade. RESULTS: After the upgrade, the cyclotron failure rate decreased by 86.2%, the average capacity increased by 45%. CONCLUSIONS: After the upgrade of MINItrace cyclotron, the failure rate is sharply reduced, and the production efficiency is grately improved.

Analysis of Performance of the MINItrace Cyclotron before and after Upgrade / 中国医疗器械杂志

OBJECTIVE@#To compare the performance of the GE cyclotron MINItrace system before and after the upgrade.@*METHODS@#The upgrade of the MINItrace system included replacing the silver target with the Nb syetem and adopting the latest RF control and management system and lastest ion source system.The failrue rate and production efficiency were retrospectively analyzed before and after the upgrade.@*RESULTS@#After the upgrade, the cyclotron failure rate decreased by 86.2%, the average capacity increased by 45%.@*CONCLUSIONS@#After the upgrade of MINItrace cyclotron, the failure rate is sharply reduced, and the production efficiency is grately improved.

An improved calibration method for the matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resononance analysis of 15N-metabolically- labeled proteome digests using a mass difference approach.

High mass measurement accuracy of peptides in enzymatic digests is critical for confident protein identification and characterization in proteomics research. Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) can provide low or sub-ppm mass accuracy and ultrahigh resolving power. While for ESI-FT-ICR-MS, the mass accuracy is generally 1 ppm or better, with matrix-assisted laser desorption/ionization (MALDI)-FT-ICR-MS, the mass errors can vary from sub-ppm with internal calibration to over 100 ppm with conventional external calibration. A novel calibration method for (15)N-metabolically labeled peptides from a batch digest of a proteome is described which corrects for space charge induced frequency shifts in FT-ICR spectra without using an internal calibrant. This strategy utilizes the information from the mass difference between the (14)N/(15)N peptide peak pairs to correct for space charge induced mass shifts after data collection. A procedure for performing the mass correction has been written into a computer program and has been successfully applied to high-performance liquid chromatography-MALDI-FT- ICR-MS measurement of (15)N-metabolic labeled proteomes. We have achieved an average measured mass error of 1.0 ppm and a standard deviation of 3.5 ppm for 900 peptides from 68 MALDI-FT-ICR mass spectra of the proteolytic digest of a proteome from Methanococcus maripaludis.

The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.

The possibility of setting up a positron emission tomography (PET) facility with a cyclotron and radiopharmaceutical laboratory in situ, at a feasible price and in a very restricted space, has led to a steady increase both in the use of the PET technique in diagnostic clinical routine imaging and in the number of cyclotrons for drug production. Owing to the progress made in the PET procedures, it is now possible to have not only a highly innovative system of diagnostic examination, with a remarkable improvement in the diagnostic quality and patient care, but also a considerable increase in the number of daily examinations. In this paper, the authors show how the acquired know-how, with respect to radioprotection, has applied to the planning, running and management of the PET/CT unit, installed in the Imaging Diagnostic Department of the Policlinico Tor Vergata (PTV), at Tor Vergata University, Rome.

A new and simple calibration-independent method for measuring the beam energy of a cyclotron.

This work recommends a new and simple-to-perform method for measuring the beam energy of an accelerator. The proposed method requires the irradiation of two monitor foils interspaced by an energy degrader. The primary advantage of the proposed method, which makes this method unique from previous energy evaluation strategies that employ the use of monitor foils, is that this method is independent of the detector efficiency calibration. This method was evaluated by performing proton activation of (nat)Cu foils using both a cyclotron and a tandem Van de Graaff accelerator. The monitor foil activities were read using a dose calibrator set to an arbitrary calibration setting. Excellent agreement was noted between the nominal and measured proton energies.

A simple method to measure proton beam energy in a standard medical cyclotron.

A simple and rapid technique to measure the proton beam energy in the external beam line of a medical cyclotron has been examined. A stack of 0.1 mm thick high purity copper (Cu) foils was bombarded and the relative activity of 65Zn produced in each foil was compared to a computational model that predicted activity, based on proton stopping power, reaction cross-sectional data, and beam energy. In the model, the beam energy was altered iteratively until the best match between computed and measured relative activities of the stack of disks was obtained. The main advantage of this method is that it does not require the comparison of the activities of different isotopes of zinc arising from (p, xn) reactions in the Cu, which would require the gamma photon detector being calibrated for different energy responses. Using this technique the proton beam energy of a nominally 18 MeV standard isochronous medical cyclotron was measured as 17.49 +/- 0.04 (SD) MeV, with a precision of 0.2% CV.

Measurements of activation products associated with Havar foils from a GE PETtrace medical cyclotron using high resolution gamma spectroscopy.

Havar foils are specially engineered for beam-line windows used in the General Electric (GE) PETtrace medical cyclotron that can withstand the high pressure differentials and also temperatures developed near the target with proton bombardment. These foils effectively separate components along the beam line of the cyclotron. Various activation products are produced in the foils from the primary proton beam and other secondary radiations. An accurate estimate of the activation products is necessary for the disposal of these foils. The foils were assayed using two High Purity Germanium (HPGe) detectors calibrated over a wide energy range. These were positioned at different distances (0.10 m, 0.24 m, and 1.74 m) away from the detector faces to accommodate their high activities. A summary of the anticipated relative abundance of each activation product and a scatter plot of the average exposure rate per unit charge incident on the foil vs. time post-activation are provided. A detailed spectral analysis of the foils in the energy ranges between 12 keV to 300 keV and 12 keV through 2,500 keV revealed the residual activation products 56Co, 57Co, 58Co, 54Mn, and 183Re at 264 d post-irradiation. Spectral examinations of the different foils removed between 2003 and 2005 show the same activation products regardless of the irradiation time or foil position in the target assembly. The information presented in this paper can be used along with the integrated charge incident on the foils in estimating the activity of Havar foils for the purpose of disposal.

Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.

Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are well- established and indispensable imaging modalities in modern medicine. State-of-the-art computed tomography (CT) scanners have now been integrated into multi-modality PET-CT and SPECT-CT devices, and these devices, particularly PET-CT scanners, are dramatically impacting clinical practice. 18F-fluorodeoxyglucose (FDG), by far the most widely used radiopharmaceutical for clinical PET imaging in general and oncologic PET imaging in particular, is highly accurate in detecting (approximately 90%) and staging many types of tumors, monitoring therapy response, and differentiating benign from malignant lesions. Several factors, including the relatively high administered activities [e.g., 370-740 MBq (10-20 mCi) of FDG], the high patient throughput (up to 30 patients per d), and in particular, the uniquely high energies (for a diagnostic setting) of the 511-keV positron-negatron annihilation photons, make shielding requirements, workflow, and other radiation protection issues important considerations in the design of a PET or PET-CT facility. The Report of Task Group 108 of the American Association of Physicists in Medicine (AAPM) provides a comprehensive summary of shielding design and related considerations, along with illustrative calculations. Whether in the form of a PET-CT or a SPECT-CT device, the introduction of CT scanners into a nuclear medicine setting has created new and complex radiation protection issues concerning the radiation burden and attendant risks accrued by patients undergoing such multi-modality procedures (especially in those instances in which higher-dose, diagnostic-quality CT studies are done as part of the PET-CT or SPECT-CT exam). In addition, because PET is dependent on the availability of short-lived 18F (Tp = 110 min) primarily in the form of FDG, and other short-lived positron emitters such as 11C (20 min), 13N (10 min), and 15O (2 min), cyclotrons for production of medically applied radionuclides and associated radiochemistry facilities are now widespread (well over 100 worldwide) and present their own radiation safety issues. In addition to the radioactive product, sources of exposure include neutrons and radioactive activation products in the various cyclotron components and surrounding shielding. Nonetheless, published studies have shown that the radiation doses to personnel working in cyclotron and associated radiochemistry facilities, as well as in PET or PET-CT and SPECT or SPECT-CT facilities, can be maintained below, and generally well below, the pertinent regulatory limits. This presentation will review the basic radiation safety aspects, including shielding and workflow, of these increasingly important and increasingly numerous facilities. The radiation burden accrued by the patients undergoing PET-CT or SPECT-CT exams will be considered as well.

Neutron dose rate in the facility at the cyclotron center of Chung Shan Medical University.

The neutron dose equivalent rate (DR) leaking from the self-shielded cyclotron was measured using an FHT-751 neutron counting system in the facility at the Cyclotron Center of Chung Shan Medical University. This system was calibrated using two (252)Cf neutron sources and simulated according to MCNP code. The results show various DRs up to 120 microSv h(-1) in the cyclotron room. Two-dimensional distributions of measured neutron DRs indicate an explicit, heavy leakage of neutrons through the self-shielded interlock. The neutron DR of the operating cyclotron that is hazardous to the health of medical personal and the public is evaluated.

Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals.

The aim of this paper is to report the data concerning the contamination of the exhausted air from the hot cells dedicated to the large-scale synthesis of positron emission tomography (PET) radiopharmaceuticals. Two cyclotrons are currently operating in Ospedale San Raffaele for the routine production of C and F. They are linked with four radiochemistry laboratories by means of shielded radioisotope delivery lines. The above labs are dedicated both to the large scale preparation and to the research and development of PET radiopharmaceuticals. The department hosts four CT-PET scanners, which operate with a mean patient workload of 40 per day. Radiosyntheses are performed using automated modules located in 10 hot cells. The air outlets are monitored online by a 2-inch NaI(Tl) counter in a Marinelli geometry counting volume. Contamination values up to 10(5) Bq L(-1) have been measured at the hot cell exit point during the synthesis. The corresponding concentrations at the point of release in atmosphere are largely above the threshold of 1.29 Bq L(-1), defined by national regulations as the limit for free environmental release. A shielded gas storage system controlled by a dedicated, customized software program has thus been installed to prevent the potentially hazardous release of gaseous radioactive contaminants. The system has allowed us to maintain the effective dose to neighboring population groups below the limit of 10 muSv y(-1).

Automatic internal calibration in liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry of protein digests.

Accurately measured peptide masses can be used for large-scale protein identification from bacterial whole-cell digests as an alternative to tandem mass spectrometry (MS/MS) provided mass measurement errors of a few parts-per-million (ppm) are obtained. Fourier transform ion cyclotron resonance (FTICR) mass spectrometry (MS) routinely achieves such mass accuracy either with internal calibration or by regulating the charge in the analyzer cell. We have developed a novel and automated method for internal calibration of liquid chromatography (LC)/FTICR data from whole-cell digests using peptides in the sample identified by concurrent MS/MS together with ambient polydimethylcyclosiloxanes as internal calibrants in the mass spectra. The method reduced mass measurement error from 4.3 +/- 3.7 ppm to 0.3 +/- 2.3 ppm in an E. coli LC/FTICR dataset of 1000 MS and MS/MS spectra and is applicable to all analyses of complex protein digests by FTICRMS.

Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59.

The Massachusetts General Hospital, the Harvard Cyclotron Laboratory (HCL), and the Massachusetts Eye and Ear Infirmary have treated almost 3000 patients with ocular disease using high-energy external-beam proton radiation therapy since 1975. The absorbed dose standard for ocular proton therapy beams at HCL was based on a fluence measurement with a Faraday cup (FC). A majority of proton therapy centers worldwide, however, use an absorbed dose standard that is based on an ionization chamber (IC) technique. The ion chamber calibration is deduced from a measurement in a reference 60Co photon field together with a calculated correction factor that takes into account differences in a chamber's response in 60Co and proton fields. In this work, we implemented an ionization chamber-based absolute dosimetry system for the HCL ocular beamline based on the recommendations given in Report 59 by the International Commission on Radiation Units and Measurements. Comparative measurements revealed that the FC system yields an absorbed dose to water value that is 1.1% higher than was obtained with the IC system. That difference is small compared with the experimental uncertainties and is clinically insignificant. In June of 1998, we adopted the IC-based method as our standard practice for the ocular beam.

Proton beam dosimetry for radiosurgery: implementation of the ICRU Report 59 at the Harvard Cyclotron Laboratory.

Recent proton dosimetry intercomparisons have demonstrated that the adoption of a common protocol, e.g. ICRU Report 59, can lead to improved consistency in absorbed dose determinations. We compared absorbed dose values, measured in the 160 MeV proton radiosurgery beamline at the Harvard Cyclotron Laboratory, based on ionization chamber methods with those from a Faraday cup technique. The Faraday cup method is based on a proton fluence determination that allows the estimation of absorbed dose with the CEMA approximation, under which the dose is equal to the fluence times the mean mass stopping power. The ionization chamber technique employs an air-kerma calibration coefficient for 60Co radiation and a calculated correction in order to take into account the differences in response to 60Co and proton beam radiations. The absorbed dose to water, based on a diode measurement calibrated with a Faraday cup technique, is approximately 2% higher than was obtained from an ionization chamber measurement. At the Bragg peak depth, the techniques agree to within their respective uncertainties, which are both approximately 4% (1 standard deviation). The ionization chamber technique exhibited superior reproducibility and was adopted in our standard clinical practice for radiosurgery.

The isochronous cyclotron: principles and recent developments.

The principals of a cyclotron are described. A magnetic field guides the ions in circular paths, while an electric field accelerates them. The main problem in any accelerator is not to accelerate ions, but to focus them. An isochronous cyclotron overrules the problems related to relativistic mass increase during acceleration. Harmonic operation and negative (vs positive) ion acceleration (and extraction) are explained, as they make dedicated PET cyclotrons a simple, reliable, and suitable tool. The characteristics of such PET cyclotrons are described, as well as their technical implementation. The IBA 18/9 PET cyclotron is given as an example.